Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 6, 2006 - Issue 3
Submit an article Journal homepage
37
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Cloretazine for the treatment of acute myeloid leukemia

Norbert Vey Department of Hematology, Institut Paoli-Calmettes, 232 Blvd Sainte Marguerite, 13009 Marseille, France. [email protected]
&
Frank Giles Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [email protected]
Pages 321-328 | Published online: 10 Jan 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gail J Roboz. (2007) Treatment of acute myeloid leukemia in older patients. Expert Review of Anticancer Therapy 7:3, pages 285-295.
Read now

Articles from other publishers (6)

Gary J. SchillerSusan M. O'BrienArnaud PigneuxDaniel J. DeAngeloNorbert VeyJonathan KellScott SolomonRobert K. StuartVerena KarstenAnn L. CahillMaher X. AlbitarFrancis J. Giles. (2010) Single-Agent Laromustine, A Novel Alkylating Agent, Has Significant Activity in Older Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia. Journal of Clinical Oncology 28:5, pages 815-821.
Crossref
Peter H. Wiernik. (2007) Leukemias and plasma cell dyscrasias. Update on Cancer Therapeutics 2:2, pages 73-99.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref
Li-mou Zheng, Zujin Li, Lanzhen Liu, Bai Louis Song & Ivan King. (2007) Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models. Cancer Chemotherapy and Pharmacology 60:1, pages 45-51.
Crossref
Francis GilesDavid RizzieriJudith KarpNorbert VeyFarhad RavandiStefan FaderlKhuda Dad KhanGregor VerhoefPierre WijermansAnjali AdvaniGail RobozHagop KantarjianSyed Fazl Ali BilgramiAugustin FerrantSimon M.G.J. DaenenVerena KarstenAnn CahillMaher AlbitarGhulam MuftiSusan O'Brien. (2007) Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, in Patients Age 60 Years or Older With Previously Untreated Acute Myeloid Leukemia. Journal of Clinical Oncology 25:1, pages 25-31.
Crossref
Latha Shivakumar, Martin S. Tallman, Vinay K. Jain & Tariq I. Mughal. (2006) Highlights from: The 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA; June 2-6, 2006. Clinical Leukemia 1:1, pages 9-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.